Refractive surgery has become a very popular method of visual correction among young myopic patients. Options range from laser in situ keratomielusis (LASIK) to the more invasive clear lens extraction (CLE) and phakic intraocular lens implantation (pIOL). Corneal surface reshaping or LASIK surgery remains the most common refractive surgery performed worldwide. 1Clear lens extraction surgery was once an option for unsuitable LASIK candidates; however, losing accommodation after the surgery is not an easy adaptation for young people. Phakic intraocular lens implantation involves insertion of a supplementary intraocular lens, while preserving the crystalline lens in its original position. Therefore, pIOL is a reasonable option for the same indication. The intraocular lens is either fixed at an angle, enclavated on the iris surface or implanted in the posterior chamber in between the iris and the lens. Posterior chamber pIOL is also known as implantable contact lens (ICL) and is gaining in popularity due to the continuous improvement in IOL design. Long-term visual outcomes are generally stable and predictable.3,4 Improvement of the pIOL design noticeably reduces anterior segment complications, 5 such as cataract, endothelial cell loss, chronic glaucoma and uveitis. Posterior segment complications are rarely reported. In theory, preserving the crystalline lens in its original position renders fewer complications as compared to CLE in a young myopic patient. Although improvement of the posterior chamber pIOL design helps in reducing anterior segment complications, the risk of posterior segment complications remains in this high-risk group of patients. This report represents a case of posterior segment complications after posterior chamber pIOL surgery.Here, we describe a case of retinal detachment in a 26-year-old man, who underwent posterior chamber pIOL surgery. The surgery was uneventful and his post-operative vision was good; however, two weeks after surgery, he presented with sudden loss of vision in the operated eye. Although an improved pIOL surgical design helps to reduce anterior segment complications, the risk of posterior segment complications remains in this high-risk group of patients. CASE REPORTA 26-year-old man had myopia (R -15.00 D and L -21.00 D) and was very keen to undergo refractive surgery after becoming intolerant to contact lenses. He was found to be unsuitable for LASIK surgery by his corneal surgeon, probably due to the very high refractive error. Details of the exclusion were not available as he was referred to us from another centre. He was scheduled for a bilateral posterior chamber pIOL implantation. Pre-operatively, multiple peripheral iridotomies were made in each eye to reduce the possible effects of pupil block. Surgery was performed on his left eye without intraoperative or early complication. The second eye was scheduled for surgery in a month.Two weeks after the procedure, he presented with sudden loss of vision in the surgically treated eye. Visual acuity was recorded as hand ...
Oklusi vena retina adalah sesuatu yang jarang berlaku dalam usia muda. Ia biasanya kurang berbahaya dan mempunyai prognosis yang baik di kalangan pesakit muda. Edema makula adalah salah satu komplikasi penyakit ini yang memerlukan rawatan dengan suntikan mata 'anti vascular endothelial growth factor'. Selain itu pesakit oklusi vena retina ini juga boleh mengalami komplikasi seperti pendarahan dalam mata dan glaukoma. Kami melaporkan kes oklusi vena retina pada seorang wanita muda yang datang kepada kami dengan aduan kabur penglihatan pada mata kiri selama empat bulan. Pemeriksaan mata menunjukkan optik disk hiperemik, saluran vena bengkak, pendarahan dalam saraf mata, edema makula dan retina lekang. Sebulan selepas menerima suntikan ranibizumab untuk makula edema, pesakit mengalami makula berlubang. Selepas empat bulan saraf berlubang telah tertutup dengan spontan tetapi masih terdapat bengkak pada bahagian makula. Komplikasi jarang seperti saraf lekang dan makula berlubang jika dikesan awal mungkin boleh diberi rawatan yang bersesuaian untuk memelihara penglihatan yang baik.
Background: Intravitreal Ozurdex® has been reported to be effective in treating macular oedema. It is more frequently used in resistant diabetic macular oedema cases that do not respond to anti vascular endothelial growth factor treatment. Despite the known risk of implant migration into the anterior chamber in non-intact posterior capsule eyes, the benefit of treatment occasionally outweighs the risk of complications, particularly in cases with good visual potential. The main potential vision-threatening complication involves permanent corneal decompensation.Case presentation: We are reporting the follow-up and management of Ozurdex implantation in non-intact capsule eyes. The complication of anterior chamber migration if at all occurred, was managed accordingly.Conclusion: Close follow-up is needed in patients with non-intact posterior lens capsules receiving intravitreal Ozurdex to monitor the risk of anterior chamber migration of the implant.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.